Urology is involved in clinical research that translates to improvements in clinical care.

Our research team is currently involved in the following areas:


  • A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men who are at High Risk for Poor Clinical Outcomes after Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men with Castration-Resistant Prostate Cancer and Men with Metastatic Prostate Cancer at Initial Diagnosis.
  • Aquablation Pilot Study for the treatment of Benign Prostatic Hyperplasia.

Bladder Cancer:

  • An observational study of efficacy of the Cxbladder urine test for the detection of urothelial carcinoma in patients presenting with macroscopic or microscopic haematuria.
  • Adding Mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a randomised phase 3 trial.

Related links